JP2022065024A5 - - Google Patents

Download PDF

Info

Publication number
JP2022065024A5
JP2022065024A5 JP2022017196A JP2022017196A JP2022065024A5 JP 2022065024 A5 JP2022065024 A5 JP 2022065024A5 JP 2022017196 A JP2022017196 A JP 2022017196A JP 2022017196 A JP2022017196 A JP 2022017196A JP 2022065024 A5 JP2022065024 A5 JP 2022065024A5
Authority
JP
Japan
Prior art keywords
composition according
dry eye
eye
trifluoromethylchroman
iriden
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022017196A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022065024A (ja
JP7248836B2 (ja
Filing date
Publication date
Priority claimed from JP2021541679A external-priority patent/JP7025094B2/ja
Application filed filed Critical
Publication of JP2022065024A publication Critical patent/JP2022065024A/ja
Publication of JP2022065024A5 publication Critical patent/JP2022065024A5/ja
Priority to JP2022171542A priority Critical patent/JP7801201B2/ja
Application granted granted Critical
Publication of JP7248836B2 publication Critical patent/JP7248836B2/ja
Priority to JP2026000075A priority patent/JP2026042857A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022017196A 2019-10-04 2022-02-07 ヘテロシクリデンアセトアミド誘導体含有医薬 Active JP7248836B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022171542A JP7801201B2 (ja) 2019-10-04 2022-10-26 ヘテロシクリデンアセトアミド誘導体含有医薬
JP2026000075A JP2026042857A (ja) 2019-10-04 2026-01-05 ヘテロシクリデンアセトアミド誘導体含有医薬

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2019184053 2019-10-04
JP2019184053 2019-10-04
JP2021541679A JP7025094B2 (ja) 2019-10-04 2020-10-02 ヘテロシクリデンアセトアミド誘導体含有医薬
PCT/JP2020/037548 WO2021066144A1 (ja) 2019-10-04 2020-10-02 ヘテロシクリデンアセトアミド誘導体含有医薬

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021541679A Division JP7025094B2 (ja) 2019-10-04 2020-10-02 ヘテロシクリデンアセトアミド誘導体含有医薬

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022171542A Division JP7801201B2 (ja) 2019-10-04 2022-10-26 ヘテロシクリデンアセトアミド誘導体含有医薬

Publications (3)

Publication Number Publication Date
JP2022065024A JP2022065024A (ja) 2022-04-26
JP2022065024A5 true JP2022065024A5 (https=) 2022-05-10
JP7248836B2 JP7248836B2 (ja) 2023-03-29

Family

ID=75338162

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2021541679A Active JP7025094B2 (ja) 2019-10-04 2020-10-02 ヘテロシクリデンアセトアミド誘導体含有医薬
JP2022017196A Active JP7248836B2 (ja) 2019-10-04 2022-02-07 ヘテロシクリデンアセトアミド誘導体含有医薬
JP2022171542A Active JP7801201B2 (ja) 2019-10-04 2022-10-26 ヘテロシクリデンアセトアミド誘導体含有医薬
JP2026000075A Pending JP2026042857A (ja) 2019-10-04 2026-01-05 ヘテロシクリデンアセトアミド誘導体含有医薬

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021541679A Active JP7025094B2 (ja) 2019-10-04 2020-10-02 ヘテロシクリデンアセトアミド誘導体含有医薬

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022171542A Active JP7801201B2 (ja) 2019-10-04 2022-10-26 ヘテロシクリデンアセトアミド誘導体含有医薬
JP2026000075A Pending JP2026042857A (ja) 2019-10-04 2026-01-05 ヘテロシクリデンアセトアミド誘導体含有医薬

Country Status (17)

Country Link
US (2) US12533337B2 (https=)
EP (2) EP4545095A3 (https=)
JP (4) JP7025094B2 (https=)
KR (1) KR20220078604A (https=)
CN (1) CN114585357A (https=)
AU (1) AU2026202464A1 (https=)
BR (1) BR112022005992A2 (https=)
CA (1) CA3156484A1 (https=)
DK (1) DK4043014T3 (https=)
ES (1) ES3031607T3 (https=)
HU (1) HUE072085T2 (https=)
MX (2) MX2022004027A (https=)
MY (1) MY207759A (https=)
PH (1) PH12022550805A1 (https=)
PL (1) PL4043014T3 (https=)
PT (1) PT4043014T (https=)
WO (1) WO2021066144A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY207759A (en) 2019-10-04 2025-03-17 Mochida Pharm Co Ltd Pharmaceutical drug containing heterocyclidene acetamide derivative
CA3215750A1 (en) * 2021-03-30 2022-10-06 Senju Pharmaceutical Co., Ltd. Suspension containing heterocyclidene acetamide derivative
AU2023352013A1 (en) 2022-09-29 2025-04-03 Mochida Pharmaceutical Co., Ltd. Combination preparation containing heterocyclidene acetamide derivative
WO2024071348A1 (ja) 2022-09-29 2024-04-04 千寿製薬株式会社 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5621566A (en) 1979-08-01 1981-02-28 Alpha- Shokuhin Kk Preparation of bifun from homegrown rice and apparatus used for it
ZA200800959B (en) * 2005-07-22 2009-10-28 Mochida Pharmaceutical Company Novel heterocyclidene acetamide derivative
RU2451014C2 (ru) 2005-07-22 2012-05-20 Мотида Фармасьютикал Ко., Лтд. Новое производное гетероциклиден ацетамида
NZ565080A (en) 2005-07-22 2011-03-31 Mochida Pharm Co Ltd Novel heterocyclidene acetamide derivative
TW200927192A (en) * 2007-11-19 2009-07-01 Alcon Res Ltd Use of TRPV1 receptor antagonists for treating dry eye and ocular pain
US20100210682A1 (en) * 2009-02-19 2010-08-19 Abbott Laboratories Repeated Dosing of TRPV1 Antagonists
EP2377850A1 (en) 2010-03-30 2011-10-19 Pharmeste S.r.l. TRPV1 vanilloid receptor antagonists with a bicyclic portion
WO2012045729A1 (en) * 2010-10-05 2012-04-12 Glaxo Group Limited Imidazo [1, 2 -a] pyridine and pyrazolo [1, 5 -a] pyridine derivatives as trpv1 antagonists
GB201215857D0 (en) * 2012-09-05 2012-10-24 Sylentis Sau siRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions
JP6230743B1 (ja) * 2017-05-31 2017-11-15 持田製薬株式会社 ヘテロシクリデンアセトアミド誘導体の結晶
JP7373909B2 (ja) 2018-04-06 2023-11-06 株式会社シマノ 変速制御装置および変速システム
MY207759A (en) 2019-10-04 2025-03-17 Mochida Pharm Co Ltd Pharmaceutical drug containing heterocyclidene acetamide derivative

Similar Documents

Publication Publication Date Title
JP2022065024A5 (https=)
JP2023011735A5 (https=)
CN105307498B (zh) 用于治疗眼病的组合物、制剂和方法
JP2018513107A5 (https=)
JP2017528507A5 (https=)
US20180000816A1 (en) Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Removing Senescent Cells in the Treatment of Eye Diseases and Other Age-Related Conditions
JP2023123442A (ja) 持続性抑制を増加させ、二次性不眠症を治療する方法
JP2012520249A5 (https=)
JP2020512364A (ja) 筋ジストロフィーの処置方法において使用するためのニンテダニブ
JP2017528503A5 (https=)
JP2023098936A5 (https=)
AU2010304755A1 (en) Use of rasagiline for the treatment of Progressive Supranuclear Palsy
JP2014525426A5 (https=)
JP2009510044A5 (https=)
JP2009526021A5 (https=)
JP2017522300A5 (https=)
JP2009544665A5 (https=)
JP2023518356A5 (https=)
JP2019535760A5 (ja) ガボキサドールを用いた注意欠陥多動性障害（ａｄｈｄ）の治療方法
Urakov et al. COVID-19: What drug can be used to treat a new coronavirus disease and why
JP2019502719A5 (https=)
JP2025517509A (ja) 脊髄小脳失調症を治療する方法
JP2020007333A5 (https=)
JP2021530440A5 (https=)
MX2023002156A (es) Acido (1r,3s)-3-((5-ciano-4-feniltiazol-2-il)carbamoil)ciclopentan o-1-carboxilico y derivados del mismo para su uso en el tratamiento de enfermedades de las vias respiratorias.